相关实验视频
Updated: May 5, 2026

09:18
Spheroid Assay to Measure TGF-β-induced Invasion
Published on: November 16, 2011
20.8K
CTGF (CCN2):乳腺癌进展和治疗向的多方面的调解者
Priya Ghosh1, Ankita Dey1, Suvendu Nandi1
1Cancer Biology Lab, School of Medical Science & Technology, Indian Institute of Technology, Kharagpur 721302, Kharagpur, West Bengal, India.
Cancer metastasis reviews
|February 13, 2025
概括
结合组织生长因子 (CTGF) 驱动乳腺癌的生长和转移. 向CTGF为各种乳腺癌亚型提供了一个有希望的治疗策略,包括ER阳性,HER-2-阳性和三阴性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 乳腺癌包括多种不同的亚型 (ER-阳性,HER-2-阳性,三阴性),需要个性化治疗.
- 遗传,环境和生活方式因素都会导致乳腺癌,乳腺癌是女性癌症死亡的主要原因.
- 连接组织生长因子 (CTGF),也称为CCN2,在乳腺癌的进展中起着重要作用.
研究的目的:
- 审查CTGF的结构和表达调节.
- 阐明CTGF在乳腺癌发育和转移中的致癌作用.
- 探索针对CTGF的潜在治疗策略.
主要方法:
- 文献综述侧重于CTGF在乳腺癌中的作用.
- 分析CTGF对瘤微环境的影响,包括血管新生和CAF.
- 检查CTGF的信号通路和乳腺癌细胞中的基因调节.
主要成果:
- 在乳腺瘤微环境中,CTGF促进细胞生长,入侵,迁移,血管生成和炎症.
- CTGF活动受到氧气水平,激素和生长因子的影响,根据乳腺癌亚型而异.
- CTGF对S100A4,GLUT3和VEGF等基因进行上调,有助于瘤发育和转移.
- 在乳腺癌中,CTGF可以赋予耐药性.
结论:
- CTGF是乳腺癌的重要致癌因素,影响多种生物过程.
- CTGF代表了乳腺癌治疗的潜在治疗标.
- 目前正在研究各种策略,包括抗体和RNA干扰,以抑制CTGF功能.
相关概念视频
Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Non-Canonical Wnt Signaling Pathways
7.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K

